Mark MCKelvie

Pet care is one of the fastest-growing consumer markets. Global spending hit $246 billion in 2023 and is projected to reach $368 billion by 2030. In the U.S., veterinary services totaled $38 billion, with pet food and products surpassing $147 billion. The market remains highly fragmented, as more than 70% of veterinary practices are independently owned, leaving room for consolidation and expansion.… Continue reading Pet Care Growth in 2025: Key Players Shaping a $368 Billion Market

One of the most important shifts underway in biotechnology is not just what therapies are being developed, but how those therapies are delivered. Traditional drug delivery methods such as oral, intravenous, or subcutaneous administration are often limited by low bioavailability, systemic toxicity, or poor targeting to the affected tissue. This has created growing demand for… Continue reading 4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)      

The biotechnology sector is entering a period of rapid growth and meaningful innovation. Global biotech revenue is expected to expand at roughly 13 to 14% annually over the next decade, moving from over US$1.5 trillion in 2024 to more than US$5 trillion by 2034. At the same time, the cell and gene therapy market is… Continue reading Biotech Movers: Four Companies Making Big Strides in Innovation and Growth (MDCX, ARQT, CRMD, MCXT)

Crypto is stirring again. Bitcoin has pushed higher, altcoins are gaining momentum, and early signs point to a new cycle taking shape. In past rallies, some of the biggest equity winners were not just exchanges or miners but public companies tied directly to token treasuries and emerging blockchains. That setup may be returning now. A… Continue reading As Digital Assets Gain Momentum, These Stocks Offer an On-Ramp (DBKSF, MSTR, ABTC, STKE)

The biotechnology sector is entering a period of rapid growth and meaningful innovation. Global biotech revenue is expected to expand at roughly 13 to 14% annually over the next decade, moving from over US$1.5 trillion in 2024 to more than US$5 trillion by 2034. At the same time, the cell and gene therapy market is poised to surge from… Continue reading Biotech Movers: Four Companies Making Big Strides in Innovation and Growth (MDCX, ARQT, CRMD, MCXT)

Global demand for critical metals, particularly copper and gold, is surging. Copper prices have climbed to roughly $4.66 per pound, up more than 13 percent over the past year, fueled by strong demand from electric vehicles, renewable energy infrastructure, and advanced electronics. Gold remains near record highs at around $3,650 per ounce, supported by expectations… Continue reading Copper and Gold Supply Crunch Creates Opportunities for Miners (CPNFF, HBM, LUN, OCANF)

Crypto is stirring again. Bitcoin has pushed higher, altcoins are gaining momentum, and early signs point to a new cycle taking shape. In past rallies, some of the biggest equity winners were not just exchanges or miners but public companies tied directly to token treasuries and emerging blockchains. That setup may be returning now. A… Continue reading As Digital Assets Gain Momentum, These Stocks Offer an On-Ramp (DBKSF, MSTR, ABTC, STKE)